Records 1 - 5
| Mutation differences in circulating tumor DNAs from non-small cell lung cancer patients between Uygur and Han populations.
Medicine 2021 Jan 100 (4): e24159.
Wang Yuli, Li Jing, Huang Jian, Wu Chaoqun, Li Li, Gong Pi
| ABCC11 gene polymorphism as a potential predictive biomarker for an oral 5-fluorouracil derivative drug S-1 treatment in non-small cell lung cancer.
Cancer chemotherapy and pharmacology 2019 Sep .
Uemura Takehiro, Oguri Tetsuya, Maeno Ken, Sone Kazuki, Takeuchi Akira, Fukuda Satoshi, Kunii Eiji, Takakuwa Osamu, Kanemitsu Yoshihiro, Ohkubo Hirotsugu, Takemura Masaya, Ito Yutaka, Niimi Ak
| Osimertinib Quantitative and Gene Variation Analyses in Cerebrospinal Fluid and Plasma of a Non-small Cell Lung Cancer Patient with Leptomeningeal Metastases.
Current cancer drug targets 2018 Oct .
Song Yuanyuan, Liu Peng, Huang Yu, Guan Yanfang, Han Xiaohong, Shi Yuank
| Geographic Variation in EGFR Mutation Frequency in Lung Adenocarcinoma May Be Explained by Interethnic Genetic Variation.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2018 03 13 (3): 454-458.
Soraas Lars, Stebbing Just
| Prognostic Impact of the ABCC11/MRP8 Polymorphism in Adjuvant Oral Chemotherapy with S-1 for Non-Small Cell Lung Cancer.
Chemotherapy 2015 Nov 61 (2): 77-86.
Tsuchiya Tomoshi, Arai Junichi, Matsumoto Keitaro, Miyazaki Takuro, Honda Sumihisa, Tagawa Tsutomu, Nakamura Akihiro, Taniguchi Hideki, Sano Isao, Akamine Shinji, Muraoka Masashi, Hisano Hiroshi, Yamasaki Naoya, Nagayasu Takes